These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 7984289
1. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells. Kooyman AR, Zwart R, Vanderheijden PM, Van Hooft JA, Vijverberg HP. Neuropharmacology; 1994; 33(3-4):501-7. PubMed ID: 7984289 [Abstract] [Full Text] [Related]
2. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells. Kooyman AR, van Hooft JA, Vanderheijden PM, Vijverberg HP. Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873 [Abstract] [Full Text] [Related]
3. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells. Brüss M, Molderings GJ, Bönisch H, Göthert M. Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422 [Abstract] [Full Text] [Related]
9. Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Cubeddu LX, Bönisch H, Göthert M, Molderings G, Racké K, Ramadori G, Miller KJ, Schwörer H. Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):85-91. PubMed ID: 10651152 [Abstract] [Full Text] [Related]
10. Allosteric potentiation of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells by 5-hydroxyindole and analogues. van Hooft JA, van der Haar E, Vijverberg HP. Neuropharmacology; 1997 Jan; 36(4-5):649-53. PubMed ID: 9225290 [Abstract] [Full Text] [Related]
11. Agonist and antagonist effects of apomorphine enantiomers on 5-HT3 receptors. van Hooft JA, Vijverberg HP. Neuropharmacology; 1998 Jan; 37(2):259-64. PubMed ID: 9680251 [Abstract] [Full Text] [Related]
12. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Wong EH, Clark R, Leung E, Loury D, Bonhaus DW, Jakeman L, Parnes H, Whiting RL, Eglen RM. Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546 [Abstract] [Full Text] [Related]
13. Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells. Lummis SC, Kilpatrick GJ, Martin IL. Eur J Pharmacol; 1990 Sep 18; 189(2-3):223-7. PubMed ID: 2253704 [Abstract] [Full Text] [Related]
14. Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine. Wikström HV, Mensonides-Harsema MM, Cremers TI, Moltzen EK, Arnt J. J Med Chem; 2002 Jul 18; 45(15):3280-5. PubMed ID: 12109911 [Abstract] [Full Text] [Related]
17. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues. Kidd FJ, Levy JC, Nielsen M, Hamon M, Gozlan H. Eur J Pharmacol; 1993 Sep 15; 247(1):45-56. PubMed ID: 8258360 [Abstract] [Full Text] [Related]
18. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells. Lummis SC, Sepúlveda MI, Kilpatrick GJ, Baker J. Eur J Pharmacol; 1993 Oct 12; 243(1):7-11. PubMed ID: 8253126 [Abstract] [Full Text] [Related]
19. Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol. Alexander BS, Wood MD. J Pharm Pharmacol; 1987 Aug 12; 39(8):664-6. PubMed ID: 2888864 [Abstract] [Full Text] [Related]
20. Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect? Pinder RM. Acta Psychiatr Scand Suppl; 1985 Aug 12; 320():1-9. PubMed ID: 2996305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]